(DTBT), representing a major determinant of mortality and morbidity. [4] [5] [6] [7] Both national and international guidelines for the management of STEMI suggest a DTBT timeframe of ⩽ 90 min from hospital presentation to first device. [1] [2] [3] More recently, evidence-based strategies to achieve a DTBT ⩽ 90 min have been incorporated into these guidelines. Strategies include a single call activation within the hospital setting and pre-hospital activation such as transmission of ECG by paramedics to alert the cardiac catheterisation laboratory. 8 There are published examples of the effect implementation of these system-based strategies has on reducing DTBT and 30-day mortality. [9] [10] [11] [12] [13] [14] [15] [16] However, there is limited data on the impact these strategies have on longerterm health outcomes.
One metropolitan Australian hospital implemented two process changes over a period of 18 months that synthesised some of these system-based strategies to improve DTBT. The first process change introduced a single and simultaneous page to the cardiology team to facilitate rapid access to the cardiac catheterisation laboratory for PPCI; this was called the 'Cath Lab Code'. The second process change integrated the Cath Lab Code with a pre-hospital notification system activated by paramedics in the field. Prior to these process changes, no coordinated approach to facilitate care for STEMI patients upon arrival to this hospital were in place. Prospective collection of DTBT on STEMI patients occurred prior to these process changes and continued throughout the implementation of process changes.
What is novel and interesting about this study is that the cohort of consecutive STEMI patients were evaluated in several ways. The objective of this study was to assess whether the implementation of process change to improve timely treatment had any impact on long-term health outcomes. Additional aims were to reveal barriers to timely management of STEMI and identify the predictors of a DTBT ⩽ 90 min.
Methods

Study design and population
This study was conducted with the approval of institutional Human Research and Ethics Committees (HRECs) and conforms with the principles outlined in the Declaration of Helsinki. 17 An observational-correlational method was used with a retrospective cohort design. The relationship between DTBT and both in-hospital and long-term health outcomes was examined on a population of 470 consecutive STEMI patients that received PPCI using a retrospective chart review. The timeframe for this review was between December 2006 and April 2011. The pre process period was until March 2008. The post process change occurred after this time. Inclusion criteria for this study were all STEMIs who presented to the emergency department at this centre, proceeded to have a PPCI and recorded a discharge diagnosis of STEMI, that is, ICD-10 code I20 and I21. Exclusion criteria were all those who did not present to the emergency department with STEMI criteria.
A chart audit tool was devised. Baseline characteristics such as age, gender and modifiable cardiac risk factors were recorded. Clinical risk profile was assessed using the Thrombolysis In Myocardial Infarction (TIMI) risk score. This composite scoring system uses age, risk factors, onset of symptoms, location of infarct and Killip class to determine the clinical risk on admission to hospital. 18 Presentation characteristics were of interest to assist in identifying potential sources of time delay to treatment revealed in the literature. [19] [20] [21] [22] Time of day and day of week were recorded, along with the mode of transport to hospital, that is, self-presentation or presentation via ambulance with or without pre-hospital notification. A presentation within the operating hours of the Cardiac Catheterisation Laboratory (Monday to Friday 0800-1800 hours) was defined as 'in hours'; anything outside this time was considered 'out of hours'. The time from onset of symptoms to hospital door time was also recorded to assess concordance with the national guidelines, with the ideal timeframe being 60-180 min. 1 The DTBT was a primary endpoint for this study. For the most part DTBT was documented prospectively. At the start of this study there was no official structure in place to expedite the management of the STEMI patient. The baseline DTBT of 'usual care' was established, and used to assess concordance with the national and international guidelines. [1] [2] [3] The study continued in context of two process changes to improve DTBT in the cardiac catheterisation laboratory. These patients had their individual DTBT measured prospectively at the time of treatment.
Immediate health outcomes such as in-hospital mortality and length of stay in days were also endpoints in this study, along with completion of inpatient cardiac rehabilitation for the indexed admission. These variables were recorded to provide a comparison between the cohort studied and the literature, which reports that timely percutaneous intervention is associated with reduced length of stays and in-hospital mortality. 16, 23 Importantly, long-term health outcomes also formed part of the primary endpoints of this study, specifically: 30-day mortality, 12-month mortality, unplanned cardiac admissions up to one-year post index admission. The Melbourne Interventional Group registry 24 provided mortality rates and unplanned cardiac admission rates up to 12 months post indexed admission. The uptake of the adjunctive services such as the outpatient based cardiac rehabilitation programme was also documented sourcing the hospital's cardiac rehabilitation department database.
Data validity
There were several measures taken to ensure validity of the data. Accurate DTBT was ensured by regular calibration of the 12 lead ECG machines in the emergency department and weekly calibration of the wall clocks in the Cardiac Catheterisation Laboratory to this website: http://www. timeanddate.com/worldclock/city. In this study, 'door time' remained defined as first medical contact in the emergency department, and balloon time was defined as the time of first balloon inflation or aspiration device. 25 These timeframes were prospectively documented and confirmed by the audit team manager. The collected data was entered onto a password protected Microsoft Excel spreadsheet. Data was entered by one and checked by another clinician to ensure data input accuracy.
Statistical analysis
Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 19 for Mac (SPPS Inc., IL, USA). Descriptive statistics were calculated to summarise the characteristics of the cohort. Categorical variables were expressed as counts and percentages. Continuous variables were expressed as mean ± standard deviation (SD) or median and inter-quartile range (IQR) as appropriate. Statistical significance was set at α = 0.05. Inferential statistics were used to investigate the relationship between the discrete variables generated from the chart audit. In particular, a comparison was undertaken for patients who presented pre process change and those who presented post the implementation of the Cath Lab Code. Additionally, a comparison was made between all those who recorded a DTBT ⩽ 90 min and all those who recorded a DTBT > 90 min.
Further analysis was performed using logistic regression to determine predictors of DTBT ⩽ 90 min. The variables used were the statistically significant variables from univariate analysis of the data. Logistic regression is reported to assist in determining which variables affect the probability of a particular outcome. 26 The goodness of fit statistic was tested using the Hosmer-Lemeshow test to ascertain whether the proportions of the variables tested were of equal magnitude. 27, 28 A power calculation was used to ensure this study was sufficiently powered. The improvement in time to treatment or DTBT was considered a primary endpoint. The recommended sample size to determine efficacy of the new Cath Lab Code and pre-hospital notification systems was calculated to be 102 patients using the software freely available at http://www.raosoft.com/samplesize.html. This was based on the data from existing hospital data which stated the median DTBT prior to any process change was 109 minutes for 156 consecutive patients. Additionally, the response distribution figure was based on the 2006 American Heart Association and American College of Cardiology (AHA/ACC) recommendations that a DTBT <90 min should be achieved 75% of the time.
Results
Between December 2006 and April 2011, the total number of patients admitted via the emergency department with STEMI to the cardiac catheterisation laboratory for PPCI and included in this study was 470. There were 362 (77%) males and the mean age of the total cohort was 64±13 years.
Comparison between the process change groups is summarised in Table 1 . There was homogeneity for all baseline clinical characteristics when comparing groups. Timely management of STEMI improved by 37 min post implementation of process change (median (IQR1-3) DTBT 109 (76-136) min vs.72 (48-97) min, p<0.001). Additionally, the percentage of patients achieving a DTBT < 90 min improved (37% vs. 69%, p<0.0001). The median (IQR1-3) length of stay was similar between groups 4 (3-5) vs. 4 (3-5) days, p=0.83. Readmission rates was also similar between groups (12.8% vs. 11.1%, p=0.68) of patients having at least one unplanned cardiac readmission. Interestingly, the unadjusted mortality rate between groups revealed a numerically higher rate for the post process change group for two of the three indexed timeframes, although this was not statistically significant: in-hospital (5.1% vs. 7.6%, p=0.31); 30-day mortality (5.1% vs. 8.0%, p=0.42). In contrast, the non-statistically significant trend of less mortality for the post process change group was at 12 months (9.0% vs. 8.6%, p=0.64).
The comparison between patients who received timely care (i.e. DTBT ⩽ 90 min) and those who did not is summarised in Table 2 . Patients with DTBT ⩽ 90 min were younger (63.0 ± 12.6 vs. 65.5± 14.2 years, p=0.05) and were male (81% vs. 73%, p<0.03). Those who recorded timely DTBT presented during business hours (55% vs. 32%, p<0.0001) and via ambulance (84% vs. 73%, p<0.004).
Patients who reported chest pain on arrival were more likely to have a DTBT ⩽ 90 min (90% vs. 83%, p<0.01). Patients who had a TIMI risk score < 5 were more likely to receive timely treatment; 62% vs. 38%, p<0.006. Interestingly, current smokers were also more likely to receive timely management (42% vs. 33%, p=0.05). Patients with a DTBT ⩽ 90 min were more likely to receive inpatient cardiac rehabilitation (88% vs. 78%, p<0.005). There was no statistically significant difference in length of stay between groups (4 (3-5) vs. 4 (3-5) days, p=0.39) or number of unplanned cardiac admissions to 12 months (11.7% vs. 11.7%, p=0.72). Patients who had a DTBT ⩽ 90 min recorded an improved survival advantage over the three indexed timeframes: in-hospital (3.7% vs. 11.2%, p<0.001); 30-day mortality (3.7% vs. 11.7%, p<0.001); 12-month mortality (3.7% vs. 15.7%, p<0.0001).
Predictors of a DTBT ⩽90 min were determined using logistic regression and are summarised in Table 3 and Appendix 1 in the Supplementary Material. Patients who presented to hospital post the implementation of process change were more likely to receive timely management (odds ratio (OR) 5.61, confidence interval (CI) 3.53-8.92, p<0.0001). Presenting during business hours (OR 3.90, CI 2.49-6.10, p<0.0001) and via ambulance (OR 2.61, CI 1.57-4.33, p<0.0001) was also a predictor of timely care. Presenting with chest pain was a strong predictor of DTBT ⩽ 90 min (OR 2.02, CI 1.31-3.13, p<0.002), along with a TIMI risk score < 5 (OR 2.36, CI 1.49-3.74, p<0.0001).
Discussion
This study examined the health outcomes to 12 months for patients presenting to hospital with STEMI and receiving PPCI, whilst hospital processes changed to improve DTBT. Findings from this study demonstrated a statistically significant and 37 min decrease in time when process changes were implemented. The achievement of timely treatment, that is, DTBT < 90 min, also improved by 32% once strategies were put in place. Our findings reaffirm the conclusions of previous studies evaluating the effect process change has on DTBT and that a coordinated approach before and upon arrival at hospital improves systems of care for the STEMI patient. [9] [10] [11] [12] [13] [14] [15] [16] One of the primary endpoints of this study was mortality, in particular long-term (12-month) mortality. The implementation of strategies to reduce DTBT had no effect on 12-month unadjusted mortality for this cohort. Indeed mortality rates were higher in the post process change group until 12 months, when it was numerically lower with no statistically significant difference identified (9.0% vs. 8.6%, p=0.64). This finding concurred with the results of a 29 The Drew study analysed the utilisation of a pre-hospital ECG programme using a randomised control design, and found no statistically significant difference in mortality between the control group and the experimental group for STEMI patients, p=0.08, or over their entire acute coronary syndrome 30 There are several possible explanations for the lack of improvement in mortality post process change in our study, some of which have been raised in a recent perspective article by Bates and Jacob. 31 In our study, the reduced time in minutes was too small to reduce infarct size given the total ischaemic time. Whilst total ischaemic time was not specifically analysed in this study, importantly, onset of symptoms was. The limitation with this metric is that onset of symptoms was retrieved retrospectively from the patient chart and was documented in 96% (n=454) of cases, making precise evaluation of total ischaemic time reliant on patient recall and clinician documentation. Pre-hospital delay that is primarily patient related is a significant barrier to timely treatment and an area that requires further exploration and operational definitions. 32, 33 This leads to the second explanation, that initiation of treatment may have been too late for some patients and hence skewed the mortality benefit. Third, it is also feasible that the widespread implementation over the past decade of evidencebased therapies for the management of STEMI has reduced mortality as much as possible. Finally, this was an observational study that examined association between groups, not causality, reducing the ability to interpret the data.
This study also examined the difference between groups for those who achieved timely treatment and those who did not, as measured by DTBT. There were several factors found to influence timely reperfusion of the culprit coronary artery. Age was shown to be a barrier to timely treatment in this cohort. The mean age was found to be significantly higher for those who did not achieve timely treatment; 63 ± 12.6 vs. 66 ± 14.2 years, p<0.03. This difference could be attributed to many factors, such as number of co-morbidities and functional limitations associated with advancing age, which in turn could delay the decision of appropriate care.
Gender was also identified as a barrier to timely intervention. There were a higher percentage of women who had a DTBT > 90 min, p <0.03. One possible explanation for this difference could be attributed to age. Interestingly, for this cohort females on average were 10 years older than males; 72 ± 12 compared with 62 ± 13 years respectively. Increased age for women presenting with STEMI is reported in the literature, along with co-morbid conditions and atypical presenting symptoms. 34, 35 An unexpected finding was that being a current smoker was associated with a lower DTBT, p=0.05. The literature is sparse but cigarette smokers are reported as more likely to present with STEMI than NSTEMI. 36 This may be partly explained by the fact that smokers have a higher propensity for coronary thrombosis, 37 which may lead to a presentation that is typical, contributing to rapid recognition of symptoms and hence timely treatment. Further investigation would be required to explore this notion.
Predictors of timely management of STEMI in this study were five-fold; presenting during business hours, presenting via ambulance, presenting with chest pain, recording a TIMI risk score <5, and presenting to hospital after the implementation of process change. This logistic regression model correctly classified cases 72% of the time with the Hosmer-Lemeshow test demonstrating goodness of fit, p=0. 29 .
Presentation during the operating hours of the cardiac catheterisation laboratory was found to be a predictor of DTBT ⩽ 90 min (OR 3.9, CI 2.496.1, p<0.0001). Time of presentation has been thoroughly explored in the literature and our findings were comparable to the effect this variable has on timely intervention. [20] [21] [22] Presentation to hospital via ambulance was also a predictor of expedited timely treatment (OR 2.6, CI 1.57-4.33, p<0.0001). This variable was dichotomised between self-presentation and any ambulance arrival, including arriving with pre-hospital notification. This finding concurred with the literature, which demonstrates a strong association between pre-hospital notification, in particular, and timely treatment. 15 Presenting with chest pain was also a predictor of a DTBT⩽ 90 min (OR 2.02, CI 1.31-3.13, p<0.002). The literature acknowledges that presenting symptoms in STEMI are often erratic, unpredictable and follow a pattern that differs in severity and quality from patient to patient. 38 Therefore it follows that ischemic chest pain that is typical in nature is more recognisable, which once confirmed with a 12-lead ECG leads to prompt treatment within the recommended 90 minutes.
A calculated TIMI risk score < 5 was a predictor of DTBT ⩽ 90 minutes (OR 2.36,CI 1.49-3.74, p<0.001). In general, a TIMI risk score < 5 reflects a level of haemodynamic stability that would allow safe and prompt transport from emergency department to the cardiac catheterisation laboratory and hence access to timely treatment.
Finally, presenting post process change to this single site tertiary level hospital was a predictor of timely management for STEMI. As aforementioned, the process changes implemented had a statistically significant effect on DTBT, and when included in the logistic regression model were considered a predictor of timely treatment (OR 5.61, CI 3.53-8.92, p<0.0001); a finding strongly supported in the literature. [9] [10] [11] [12] [13] [14] [15] [16] 
Limitations
The limitations of this research include the absence of randomisation and the difficulty in blinding data where exposure may be linked to hidden confounders, decreasing the ability to generalise. The lack of an all-purpose mechanism for controlling confounding variables is recognised as a limitation to the research method. 39 Furthermore, whilst DTBT was measured prospectively, demographic and procedural characteristics were retrospectively collected with a chart review. When data is extracted retrospectively it is a conservative estimate of what is done and which has also been documented.
Summary
This original investigation has reported on a cohort of consecutive STEMI patients and analysed the health outcomes in several ways. The comparison between time to treatment, as measured by DTBT, revealed a statistically significant difference in unadjusted mortality rates to 12 months for those who had a DTBT ⩽ 90 min, but not for the same cohort of patients post implementation of strategies to improve processes of care. Given the fact that timely treatment improved with the implementation of process change it was disappointing that this did not translate to improved mortality. Further study is required to analyse these results and determine the characteristics of the patient groups failing to achieve DTBT ⩽ 90 min. Targeted management could then be applied to negate the contributing factors to prolonged management in STEMI.
Implications for practice
• • Timely management improves 12-month mortality. • • Process changes do not affect 12-month mortality.
• • Ambulance presentation in office hours with chest pain and Thrombolysis In Myocardial Infarction risk score < 5 are predictors of timely management.
